Skip to main content
OpenTrials
Completed

NCT Number: NCT03846908

Postprandial Lipid Metabolism in Patients With Hypertriglyceridemia and Normo-lipidemic Controls: Medium Chain Fatty Acids (MCT) in Comparison to Long-chain, Saturated Fatty Acids (SFA) and Mono-unsaturated Fatty Acids (MUFA)

Postprandial lipid metabolism will be evaluated in patients with hypertriglyceridemia and normo-lipidemic controls; different fats will be used (saturated fatty acids, mon-unsaturated fatty acids and medium chain fatty acids) for the oral fat challenge.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Munich

Munich, 81377, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • hypertriglyceridemia (150 mg/dl-900 mg/dl)

Exclusion criteria

  • Lipid lowering drugs or indication for Lipid lowering drugs
  • LDL-cholesterol > 190 mg/dl
  • Diabetes mellitus

Treatment and study plan

MCT

Other

patients will receive fat load with MCT

SFA

Other

patients will receive fat load with SFA

MUFA

Other

patients will receive fat load with MUFA

Primary outcomes

  1. postprandial hypertriglyceridemia

    Time frame: 8 hours after fat meal

    area under the curve following oral fat load

Sponsors and collaborators

Lead sponsor

Ludwig-Maximilians - University of Munich

Other

Registry information

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Feb 20, 2019
Registry last updated
Sep 14, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.